|
December 13, 2000
|
|
PUBLIC
HEALTH
The Infection Connection
Reducing high rates of post-surgery infections is becoming a national
priority
By Lara Pullen, Ph.D.
f
you've ever had surgery, you know that the operation was intended
to make you feel better, not worse. In light of recent publicity
on medical errors, however, many hospitals are scrambling to reduce
what is generally believed to be an unacceptably high level of
post-surgery infections. These infections that are specifically
associated with being treated in a hospital are known as nosocomial
infections. Unfortunately, depending on the patient type and surgery,
as many as 30 percent of individuals who undergo surgery experience
post-surgery infection. For 18 percent of these people, the infection
persists for six months or longer.
While these statistics sound alarming, Dr. James McCoy, Vice
President of Clinical Integration at Advocate Health Care in Illinois,
is reassuring when he states that at any reputable hospital, the
rates of post-surgery infection tend to be quite low and that
most consumers would be "unlikely to distinguish between hospitals."
He emphasizes that every hospital is required by the accreditation
committee to track and report the rates of nosocomial infections.
Nonetheless, when averaged across the country, approximately
2-10 percent of hospitalized patients develop nosocomial infections.
The tremendous cost of treating these infections -- between $32
and $825 million annually -- ensures that these infections are
not only a concern for patients but also for the business-minded
folks at the hospital.
|
|
When averaged across the country, approximately 2-10
percent of hospitalized patients develop nosocomial
infections -- and these infections account for between
$32 and $825 million excess costs annually.
|
|
|
|
On many levels, then, the reduction of nosocomial infections
is a national priority. Thus far, strategies include the enforcement
of stringent sanitation standards and a new use for a common antibiotic
ointment.
Stealth bacteria
Researchers have determined that the two organisms most likely
to cause post-surgery infections are Escherichia coli and
Staphylococcus aureus. E. coli, which has gained some fame
in recent years as a contaminant in uncooked hamburger meat, most
commonly causes gastrointestinal disorders. S. aureus causes
what are known as staph infections, or skin infections. Generally,
E. coli and staph infections are most dangerous for the
elderly, children, and those with a compromised immune system.
While patients undergoing hospitalization may not be technically
immunocompromised, they are more vulnerable than are healthy individuals
going about their daily routine. One of the largest contributions
to this vulnerability is the fact that they have a point of entry
for the bacteria: the surgical wound.
Prevention
In many ways, the prevention of nosocomial infection is similar
to the everyday strategies that we all use to protect ourselves
from disease. Hospitals routinely perform procedures such as handwashing,
identification of potentially infected patients, isolation of
individuals known to be infected, and cleaning the environment.
Because the stakes in the battle against infection are higher
in the hospital setting than they are at home, hospitals have
a few more tools at their disposal. Dr. Trish M. Perl of Johns
Hopkins University, Baltimore, Maryland, is an infectious disease
specialist who studies nosocomial infection rates and tests strategies
designed to reduce those rates. This summer she presented the
results of her recent research on the ability of mupirocin, an
antibiotic, to prevent post-surgery infection.
Ointment to the rescue
Mupirocin (trade name Bactroban) is specifically designed to
prevent the spread of S. aureus in the hospital setting.
Unlike the antibiotics that are commonly prescribed and taken
orally, mupirocin is applied in the nose with a special applicator.
To be effective, the physician must prescribe mupirocin during
the pre-operative appointment. The patient then applies the ointment
twice daily beginning five days prior to surgery.
Patients that receive at least six doses of the ointment have
a 90 percent reduction in the S. aureus nosocomial infection
rate. This rate can translate into better health for the patient
and, consequently, a better financial bottom line for the hospital.
And according to Dr. Perl, mupirocin is "a pretty benign drug,"
with occasional side effects such as headache, sneezing, and runny
nose.
While mupirocin is occasionally used as part of a strategy to
prevent nosocomial infections, it is more commonly used in patients
who are especially susceptible to infections, such as individuals
with diabetes or those who are HIV-positive. Mupirocin may become
more common in the future if the results from the upcoming follow-up
clinical trial continue to support its efficacy.
So, if you or a loved one have a surgery planned in your near
future, don't be surprised if your doctor gives you an ointment
to wipe in your nose. That ointment just might make your stay
in the hospitals days, or months, shorter.
Related link:
Send feedback
on this article.
December 13, 2000
f you've ever had surgery,
you know that the operation was intended to make you feel better,
not worse. In light of recent publicity on medical errors, however,
many hospitals are scrambling to reduce what is generally believed
to be an unacceptably high level of post-surgery infections. These
infections that are specifically associated with being treated in
a hospital are known as nosocomial infections. Unfortunately, depending
on the patient type and surgery, as many as 30 percent of individuals
who undergo surgery experience post-surgery infection. For 18 percent
of these people, the infection persists for six months or longer.
While these statistics sound alarming, Dr. James McCoy, Vice President
of Clinical Integration at Advocate Health Care in Illinois, is reassuring
when he states that at any reputable hospital, the rates of post-surgery
infection tend to be quite low and that most consumers would be "unlikely
to distinguish between hospitals." He emphasizes that every hospital
is required by the accreditation committee to track and report the
rates of nosocomial infections.
Nonetheless, when averaged across the country, approximately 2-10
percent of hospitalized patients develop nosocomial infections. The
tremendous cost of treating these infections -- between $32 and $825
million annually -- ensures that these infections are not only a concern
for patients but also for the business-minded folks at the hospital.
|
|
When averaged across the country, approximately 2-10 percent
of hospitalized patients develop nosocomial infections --
and these infections account for between $32 and $825 million
excess costs annually. |
|
|
|
On many levels, then, the reduction of nosocomial infections is a
national priority. Thus far, strategies include the enforcement of
stringent sanitation standards and a new use for a common antibiotic
ointment.
Stealth bacteria
Researchers have determined that the two organisms most likely to
cause post-surgery infections are Escherichia coli and Staphylococcus
aureus. E. coli, which has gained some fame in recent years as
a contaminant in uncooked hamburger meat, most commonly causes gastrointestinal
disorders. S. aureus causes what are known as staph infections,
or skin infections. Generally, E. coli and staph infections
are most dangerous for the elderly, children, and those with a compromised
immune system.
While patients undergoing hospitalization may not be technically
immunocompromised, they are more vulnerable than are healthy individuals
going about their daily routine. One of the largest contributions
to this vulnerability is the fact that they have a point of entry
for the bacteria: the surgical wound.
Prevention
In many ways, the prevention of nosocomial infection is similar to
the everyday strategies that we all use to protect ourselves from
disease. Hospitals routinely perform procedures such as handwashing,
identification of potentially infected patients, isolation of individuals
known to be infected, and cleaning the environment.
Because the stakes in the battle against infection are higher in
the hospital setting than they are at home, hospitals have a few more
tools at their disposal. Dr. Trish M. Perl of Johns Hopkins University,
Baltimore, Maryland, is an infectious disease specialist who studies
nosocomial infection rates and tests strategies designed to reduce
those rates. This summer she presented the results of her recent research
on the ability of mupirocin, an antibiotic, to prevent post-surgery
infection.
Ointment to the rescue
Mupirocin (trade name Bactroban) is specifically designed to prevent
the spread of S. aureus in the hospital setting. Unlike the
antibiotics that are commonly prescribed and taken orally, mupirocin
is applied in the nose with a special applicator. To be effective,
the physician must prescribe mupirocin during the pre-operative appointment.
The patient then applies the ointment twice daily beginning five days
prior to surgery.
Patients that receive at least six doses of the ointment have a 90
percent reduction in the S. aureus nosocomial infection rate.
This rate can translate into better health for the patient and, consequently,
a better financial bottom line for the hospital. And according to
Dr. Perl, mupirocin is "a pretty benign drug," with occasional side
effects such as headache, sneezing, and runny nose.
While mupirocin is occasionally used as part of a strategy to prevent
nosocomial infections, it is more commonly used in patients who are
especially susceptible to infections, such as individuals with diabetes
or those who are HIV-positive. Mupirocin may become more common in
the future if the results from the upcoming follow-up clinical trial
continue to support its efficacy.
So, if you or a loved one have a surgery planned in your near future,
don't be surprised if your doctor gives you an ointment to wipe in
your nose. That ointment just might make your stay in the hospitals
days, or months, shorter.
Related link:
Send feedback on this article.
|